I nflammation is a fundamental mechanism in maintaining homeostasis in response to tissue damage and invading pathogens. Innate immune sensors constantly survey organisms for signs of dyshomeostasis or the presence of foreign molecules to initiate adequate responses. Inflammasomes are intracellular multiprotein complexes consisting of a sensor protein of the AIM2-like or NOD-like receptor (NLR) families, the adaptor molecule apoptosis associated speck-like protein containing a CARD (ASC), and the IL-1b processing cystein protease caspase-1 (1) (2) (3) . The assembly of inflammasomes is triggered by a wide range of molecules during infection, tissue damage, or alterations of cellular homeostasis (1, 4) . Upon formation of inflammasomes, caspase-1 proteolytically cleaves different proteins, including the proforms of IL-1b and IL-18, into active cytokines and facilitates their release by nonclassical secretion (5) . IL-1b is a master cytokine of local and systemic inflammation and plays a central role in a growing list of human diseases (6, 7) . IL-1b binds to the IL-1 receptor in target cells and induces more inflammatory mediators (8) . IL-1b and IL-18 also promote the generation and maintenance of IFN-g-and IL-17-producing T cells, which has implications for autoimmune disorders such as multiple sclerosis and type 1 diabetes (9) . Independently from cytokine processing, caspase-1 also induces inflammatory cell death, named pyroptosis (10) (11) (12) .
NLRP3 is an intracellular signaling molecule belonging to the NLR family, activated by a wide range of chemically diverse pathogen-and host-derived factors (4, 13) . The exact mechanism of NLRP3 activation remains unclear despite extensive research. Published data suggest that the NLRP3 inflammasome is activated by potassium efflux, lysosomal destabilization or mitochondrial dysfunction (4) . The regulation of the NLRP3 inflammasome by redox-related mechanisms, however, is controversial (2, (14) (15) (16) (17) (18) .
Intriguingly, lowering bioavailable copper attenuates inflammation, and inhibits angiogenesis and tumor cell proliferation in various cancer models in vitro and in vivo; however, the underlying mechanisms are not well understood (19) (20) (21) . We investigated the impact of copper-chelating drugs on inflammatory reactions and found that tetrathiomolybdate (TTM), which complexes copper by forming a tripartite bond with this cation and protein (22) , specifically inhibits NLRP3 inflammasome activation. Copper depletion abrogates canonical NLRP3, but not other inflammasomes in macrophages by chelating this cation specifically from superoxide dismutase 1 (SOD1), which blocks its enzymatic activity and thereby alters the intracellular redox milieu (20) . Importantly, copper is required for inflammasome activation in vivo because TTM treatment protects mice from LPS-induced endotoxic shock. Our data reveal a hitherto unknown copper-dependent regulatory mechanism for NLRP3 inflammasome activation in macrophages. Because treatment with TTM is approved for clinical use, for example for patients with Wilson's disease (23) , our results open the door for novel anti-inflammatory treatment strategies for a wide range of NLRP3-mediated diseases.
Materials and Methods

Ethics statement
This study was conducted in accordance with the Helsinki Declaration. Peritoneal ascites fluid was collected with informed consent of the patients and with approval from the ethics committee of the Charité Universitätsmedizin Berlin (EA2/094/13).
Mice SOD1-and NLRP3-deficient mice were purchased from the Jackson Laboratory on a C57BL/6 background or for more than 10 generations backcrossed on a C57BL/6 background. Caspase-1/-11-deficient mice were obtained from BASF. All mice were housed under specific pathogen-free conditions in the animal facility of the Max Planck Institute for Infection Biology, Berlin. All mouse experiments were carried out in the S2 area of the Max Planck Institute for Infection Biology, Berlin, with sex-and agematched 8-12 wk old mice. Experiments were done in accordance with the German Animal Protection Law and approved by the Landesamt f€ ur Gesundheit und Soziales, Berlin (G0064/12).
Isolation of human macrophages from ascites fluid
Ascites fluid from therapeutic paracentesis from patients with chronic ascites in the department of gastroenterology at the Charité, Berlin, was anonymously obtained in accordance with the Charité ethics committee. Ascites fluid was spun at 200 g for 15 min and the cellular pellet was resuspended in PBS containing 2 mM EDTA and 100 U/ml penicillin/ streptomycin. The cell suspension was layered on Histopaque 1077 (Sigma-Aldrich) and centrifuged for 40 min at 400 3 g. The mononuclear cell layer was aspirated, washed, and cultivated in DMEM supplemented with 2% (v/v) human serum, 2 mM L-glutamine, penicillin/streptomycin, and 10 mM HEPES on cell culture petri dishes for adherent cells. After 2 h, the nonadherent cells were washed off. The purity of cells was determined by FACS.
Isolation of human blood-derived monocytes
Blood from healthy volunteers was drawn in EDTA-coated vacutainers and diluted in PBS supplemented with 2 mM EDTA. Up to 30 ml of blood was layered on 15 ml of Histopaque 1077 and centrifuged at 400 3 g and 21˚C for 30 min. The PBMCs were collected and washed with PBS/EDTA. Platelets were depleted by repeated centrifugation at 200 3 g for 15 min. Monocytes were isolated from PBMCs by negative selection using the Monocyte Isolation Kit II (Miltenyi Biotec) according to the manufacturer's instructions. Monocytes were cultivated in RPMI 1640 medium supplemented with 100 U/ml penicillin/streptomycin and 5% human serum (Sigma-Aldrich), and used for experiments the next day. For the experiments with monocyte-derived macrophages, monocytes were differentiated into macrophages in M1 or M2 differentiation medium (Promo Cell) for 6 d. Purity of monocytes and macrophages was more than 96% as determined by a fluorescent-activated cell sorter using anti-CD14 Ab (Miltenyi Biotec).
Isolation and generation of murine myeloid cells
For peritoneal macrophages, mice were injected with 1 ml of sterile 6% (w/v) thioglycolate solution and cells were harvested by peritoneal lavage with prewarmed sterile PBS 5 d later. Cells were washed and erythrocytes were isotonically lysed at room temperature. Macrophages were cultured in DMEM supplemented with 10% (v/v) heat-inactivated FCS, 100 U/ml penicillin/ streptomycin, and 2 mM L-glutamine under standard conditions at 37˚C and 5% (v/v) CO 2 , and adherent cells were used for experiments after overnight incubation. In vitro assays were performed in DMEM containing 2% FCS. Bone marrow-derived macrophages (BMDMs) were prepared from the femurs of mice and cultivated with DMEM containing 10% FCS, 10 mM HEPES, 1 mM pyruvate, 10 mM L-glutamine, and 20% M-CSFconditioned medium derived from L929 fibroblast cultures. The cells were incubated at 37˚C and 5% CO 2 , and macrophages were harvested after 6 d in culture. Murine PBMCs were purified by drawing maximum 100 ml of blood per animal and layered onto Histopaque 1077, and centrifuged for 30 min at room temperature at 400 3 g.
Inflammasome activation assays in vitro
Cells were seeded at 1 3 10 6 per ml in DMEM supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin/streptomycin, 10 mM HEPES, and incubated at 37˚C with 5% CO 2 . Cells were primed with 500 ng/ml ultra-pure LPS (Salmonella typhimurium, S-form LPS; Enzo Life Sciences) for 3 h and subsequently stimulated with ATP (5 mM) or nigericin (10 mM) for 1 h or the indicated period of time, silica (100 mg/ml) for 90 min or lethal toxin from Bacillus anthracis (LTx) at 1 mg/ml for each compound, lethal factor and protective Ag, recombinantly expressed in Escherichia coli BL21 (DE3), and affinity purified for 2 h. To study the AIM2 inflammasome, cells were transfected with poly(desoxyadenylicdesoxythymidylic) acid [poly(dA:dT)] using Lipofectamine 2000 (Life Technology) at a concentration of 1 mg DNA plus 3 ml Lipofectamine per milliliter. Supernatants were collected 3 h after transfection. As control, independent wells were treated with transfection reagent in the same concentration without poly(dA:dT). To activate caspase-11 via the alternative pathway, cells were primed for 3 h with 500 ng/ml synthetic triacetylated lipoprotein (Pam3CSK4; Life Technology), a TLR1/2 ligand, prior to stimulation with 20 mg/ml cholera toxin, subunit B (CTxB), and 10 mg/ml LPS (E. coli, serotype O111:B4; Sigma-Aldrich). Supernatants were collected after 8 or 16 h. Supernatants were removed and analyzed using ELISA (DuoSet; R&D Systems). Lactate dehydrogenase (LDH) release was measured using the CytoTox96 nonradioactive cytotoxicity assay (Promega). Lysed cells in medium with 1% Triton X-100 served as a reference for maximal cell death. For bacterial infections with E. coli (at multiplicity of infection [MOI] 50), Citrobacter rodentium (at MOI 50) or Shigella flexneri (M90T; at MOI 25) cells were incubated for 90 min, before medium was supplemented with 100 mg/ml gentamicin (Life Technologies). For quantification of ASC specks, immortalized murine macrophages expressing transgenic ASC-mCherry fusion protein were primed with LPS and stimulated as indicated in albumin-precoated low bind tubes, and fixed with paraformaldehyde. The fixed cells were measured and quantified using an AMNIS imaging flow cytometer (Merck Millipore).
For coimmunoprecipitation experiments, cells were stimulated as indicated and lysed in cold NP-40 lysis buffer (1% Tx-100, 50 mM Tris-HCl at pH 7.4, 150 mM NaCl) supplemented with Roche Complete Protease Inhibitor. Flag-tagged proteins were immunoprecipitated with Anti-FLAG M2 Magnetic Beads (M8823; Sigma-Aldrich). The cell lysates were incubated with the magnetic beads for 3 h at 4˚C before being washed in a magnetic separator.
Immunoblotting
For cell lysates, supernatant of adherent cells was removed and cells were lysed in 1% Triton X-100 in PBS supplemented with protease inhibitor for 10 min on ice. Lysate was centrifuged at 10,000 3 g for 5 min and supernatants were decanted for further analysis. Cell culture supernatants were precipitated by the addition of equal volumes of methanol and 0.25 vol of chloroform, vortexed, and centrifuged 15 min at 16,000 3 g. The interphase was precipitated with methanol, again vortexed, and centrifuged for 15 min at 16,000 3 g. The pellet was dried at 55˚C and suspended in Laemmli loading buffer and further subjected to gel electrophoresis. After transfer using a semidry or wet blotting system polyvinylidene difluoride membranes were blocked with 1% (w/v) BSA in PBS with 0.1% (v/v) Tween-20 for 1 h at room temperature. Membranes were incubated with primary Abs in PBS with 0.1% (v/v) Tween-20 with 0.1% (w/v) BSA and secondary Abs conjugated to HRP. For visualization membranes were incubated with ECL substrate (ECL Western Blot Substrate; Pierce) and the signal was detected with photographic films (Hyperfilm ECL; GE Healthcare). For reprobing, polyvinylidene difluoride membranes were incubated with stripping buffer (Restore Stripping Buffer; Pierce) for 30 min at room temperature and washed extensively before blocking and reprobing.
Reagents and Abs
Ultra-pure LPS from S. typhimurium (S-type) was from Enzo Life Sciences, LPS derived from E. coli (serotype O111:B4), and ATP was from Sigma-Aldrich. Nigericin and poly(dA:dT) was from InvivoGen; Lipofectamine 2000 and all cell culture reagents were purchased from Life Technology. Recombinant IFN-g was from Miltenyi Biotec. The following Abs were used: mouse caspase-1 (kindly provided by P. Vandenabeele, Ghent), mouse IL-1b (ab9722; Abcam), mouse SOD1 (FI-154; Santa Cruz), mouse ASC (sc-22514-R; Santa Cruz), mouse phospho-p38 (9216; Cell Signaling), mouse p38 (9212; Cell Signaling), mouse IkBa (400 001; Calbiochem), mouse phospho-Erk (9101; Cell Signaling), mouse Erk (9102; Cell Signaling), mouse caspase-11 (clone 17D9; Novus Biologicals), and mouse NLRP3 (ab4207; Abcam). For immunoprecipitation experiments immunoblots were probed with Abs against NEK7 (ab133514 by Abcam) and NLRP3 (cryo2; AG-20B-0014, C100 by Adiopgen).
Measurement of reactive oxygen species and glutathione
For detection of intracellular reactive oxygen species (ROS), cells were incubated for 20 min at 37˚C with 10 mM CM-H2DCFDA (Molecular Probes), then washed with PBS and resuspended in RPMI 1640 with 0.5% (v/v) FCS without phenol red. Intracellular ROS was quantified by flow cytometry using a MACSQuant flow cytometer (Miltenyi Biotec) and data were analyzed with FlowJo Version 10. The concentration of reduced glutathione (GSH) was measured colorimetrically using the glutathione [glutathione disulfide (oxidized GSH)(GSSG)/GSH] detection kit (Enzo Life Sciences).
Immunofluorescence
Peritoneal macrophages were seeded on uncoated glass coverslips and cultivated overnight in DMEM supplemented with 10% (v/v) FCS, 100 U/ml penicillin/streptomycin, and 2 mM L-glutamine under standard conditions at 37˚C and 5% (v/v) CO 2 . Attached cells were primed and stimulated before fixation in 2% paraformaldehyde for 15 min at room temperature, then permeabilized with 0.1% Triton X-100 in PBS for 15 min at room temperature, and blocked in PBS with 2% BSA and 5% rat serum for 30 min. Cells were stained with monoclonal anti-ASC Ab from rat (clone 8E4.1) followed by Cy3-labeled secondary Abs (Jackson Laboratory). Finally, cells were counterstained with anti-CD11b-FITC-conjugated Abs (Miltenyi Biotec) and Hoechst 33258. Coverslips were mounted using ProLong Gold anti-fade mountant (Molecular Probes). Imaging was performed using a Leica TCS SP8 confocal microscope.
Histology
Murine spleens were fixed in 4% (w/v) paraformaldehyde in PBS and paraffin embedded. Paraffin sections 4 mm thick were stained using routine H&E staining or with Abs against cleaved caspase-3 (clone 5A1E; Cell Signaling) by using the iVIEW DAB Detection Kit (Ventana, Tucson, AZ) with biotinylated secondary Abs and diaminobenzidine visualization of the peroxidase reaction product with a Benchmark XT immunostainer (Ventana). For the TUNEL staining, spleens from treated mice were fixed at 4˚C for 24 h in 4% (w/v) paraformaldehyde in PBS solution, washed with PBS, with a stepwise increased sucrose concentration from 10% per 24 h to 30% (w/v) sucrose in PBS. The sucrose-soaked spleens were embedded in Tissue-Tec OCT (Sakura) and cut in 7 mm slices using a cryomicrotome. The DeadEnd Fluorometric TUNEL System (Promega) was used according to the manufacturer's instructions to label fragmented DNA of apoptotic cells by catalytically incorporating fluorescein-12-dUTP at 39-OH DNA ends using a terminal deoxynucleotidyl transferase. The fluorescein-12-dUTP-labeled DNA was visualized by fluorescence microscopy and quantified using Image J software.
LPS-induced endotoxic shock model
Age-and sex-matched mice were injected peritoneally with 15 mg/kg LPS derived from E. coli (serotype O111:B4; Sigma-Aldrich). The mice were monitored for signs of pain and severe suffering every 6 h. For cytokine measurements, an independent cohort of mice received 15 mg LPS per kilogram body weight and mice were anesthetized by inhalative isoflurane prior to blood draw from the retroorbital venous plexus into fast clotting serum tubes with separating gel (Becton Dickinson). Blood samples were incubated at room temperature for 10 min and centrifuged for 7 min at 10,000 3 g and stored at 220˚C. Cytokine concentrations were determined by ELISA or multiplex bead-based assays (Bio-Rad).
Statistical analysis
For technical multiplicates, data were plotted as mean plus SD. Biologically independent multiplicates were statistically analyzed by nonparametric (Mann-Whitney U test) or parametric tests (Student t test) as indicated and plotted as mean plus SEM. Paired datasets (e.g., time course of identical individuals) were analyzed by paired nonparametric tests. The survival of mice was analyzed by log-rank test. p , 0.05 was considered statistically significant.
Results
Depletion of bioavailable copper attenuates inflammasome activation in vivo
Because copper chelation was reported to attenuate LPS-induced responses (24), we tested the effect of TTM in a model of acute inflammation in vivo. We treated mice i.p. for 2 d with 20 mg/kg per day of this chelator before administering a lethal dose of 15 mg/kg LPS i.p. Caspase-1-dependent cytokines, such as IL-1b and the downstream inflammatory mediators IFN-g and IL-17A, were significantly reduced in the serum of mice pretreated with copper chelator compared with untreated controls. In contrast, the caspase-1-independent cytokines RANTES, KC, and TNF were not affected by TTM pretreatment (Fig. 1A ). Mice treated with this chelator were also significantly more resistant to endotoxic shock than untreated littermates. Notably, the survival rate of treated mice was comparable to mice deficient in caspase-1/-11 ( Fig. 1B ). In addition, copper chelation significantly lowered free histone-DNA complexes and HMGB1 concentrations, which serve as sepsis markers (25, 26) , in the serum 24 h after LPS injection (Fig. 1C ). We also observed less lymphocyte apoptosis in the spleens of LPS-treated mice in combination with copper chelation ( Fig. 1D ) and confirmed the phenotype by staining the tissue sections for cleaved caspase-3, and visualized apoptotic cells using a TUNEL assay ( Fig. 1D ). Our data suggest that depletion of bioavailable copper specifically inhibits caspase-1 activation in vivo.
Copper is required for canonical NLRP3 inflammasome activation in vitro
We tested whether copper chelation downregulates caspase-1 activity in vitro. TTM strongly reduced IL-1b release from BMDMs in a dose-dependent manner after NLRP3 activation with ATP, nigericin, or silica (Fig. 1E ). The calculated half-maximal inhibitory concentration was 4.07 mM for nigericin [IC 50 (95% confidence interval) 2.1-6.03], 5.18 mM for ATP (5.07-6.56), and 3.55 mM for silica (0.27-6.83) ( Fig. 1E ). Furthermore, copper chelation reduced the release of mature IL-18 and prevented pyroptosis in response to all three stimuli (Supplemental Fig. 1A-F ). Caspase-1 activation was also sensitive to copper depletion as indicated by the absence of the autoproteolytic p20 fragment of caspase-1 in lysates of LPS-primed and NLRP3-activated BMDMs. However, priming was unaffected by copper depletion as indicated by comparable protein levels of pro-IL-1b and NLRP3 (Fig. 1F) . Importantly, the inhibitory effect of TTM was completely reverted by adding divalent copper ( Fig. 1G, Supplemental Fig. 1G ), up to a TTM/metal ion molar ratio of 1:1. Other divalent metal ions did not show any effect on IL-1b secretion even at a 10 mM concentration (Supplemental Fig. 1G, 1H ), demonstrating that TTM-mediated NLRP3 inhibition is copper specific.
Immunoblot analysis revealed that copper chelation did not affect phosphorylation of ERK and p38 MAPK, or degradation of IkB in BMDMs (Supplemental Fig. 2A ). Importantly, caspase-1 activation was inhibited by copper chelation even in the absence of LPS priming in macrophages overexpressing NLRP3 (Supplemental Fig. 2B ). Finally, secretion of KC, IL-6, and TNF was not copper sensitive in BMDMs activated with LPS and ligands to activate innate immune receptors, including the TLRs (Supplemental Fig. 2C ). These data suggest that copper chelation specifically blocks caspase-1 activation without affecting NF-kBdependent priming in BMDMs.
NLRP1, NLRC4, AIM2, and noncanonical inflammasomes do not require copper
We further evaluated whether copper is required for the activation of NLRP3-independent inflammasomes. Copper chelation did not affect IL-1b secretion or pyroptosis after activation of the AIM2 inflammasome by transfection of LPS-primed wild-type and NLRP3-deficient macrophages with the dsDNA analog poly(dA: dT) ( Fig. 2A, 2B) (27) (28) (29) . ATP and nigericin served as internal controls for NLRP3-dependent and copper-sensitive stimuli. We infected BMDM with virulent S. flexneri and observed that TTM did not block IL-1b or cell death, demonstrating that NLRC4 inflammasome activation does not require copper either (Fig. 2G ) (30) . Furthermore, LPS-primed wild-type BMDMs from mouse strains expressing functional NLRP1 alleles [such as BALB/c and 129-S2 (31)] released IL-1b and LDH in the presence of the copper chelator in response to recombinant LTx (Fig. 2H) . Previous studies have shown that the TLR7 agonist imiquimod, a small molecule that blocks the quinone oxidoreductase NQO2, activates NLRP3 independent from K + efflux (32, 33) . Interestingly, The Journal of Immunology imiquimod-dependent NLRP3 inflammasome activation was also effectively blocked by TTM, suggesting that TTM acts upstream of NLRP3 activation on a target that is shared by different NLRP3 agonists (Fig. 2I ). Therefore, we tested whether TTM blocks the association of NLRP3 and NEK7, a serine-threonine kinase recently identified upstream of NLRP3 inflammasome (34) (35) (36) activation. In immunoprecipitation experiments with immortalized macrophages expressing transgenic NLRP3 (previously used, see Supplemental Fig. 2B) , we accordingly observed a strongly reduced association of NLRP3 with NEK7 upon treatment with TTM ( Fig. 2J) .
Gram-negative bacteria, such as E. coli and C. rodentium, and intracellular LPS can be sensed by a noncanonical pathway, which treatment (100%) and plotted as means 6 SD of technical triplicates; nonlinear regression analysis was performed. The data are representative of at least three independent experiments. (F) Immunoblots of cell lysates and supernatants from BMDMs primed and stimulated as indicated above, treated with or without 10 mM TTM. (G) Secretion of IL-1b from LPS-primed BMDMs pretreated with or without TTM in the presence of divalent cations at 10 mM and stimulated with nigericin. Bars show means 6 SD of technical triplicates; the data are representative of three independent experiments. results in caspase-11-dependent cell death and NLRP3-dependent caspase-1 activation (37-40). We infected wild-type and NLRP3deficient BMDMs with either E. coli or C. rodentium or treated cells with CTxB and LPS (E.coli serotype O111/B4) to test whether this noncanonical inflammasome activation is sensitive to copper depletion ( Fig. 2C-F) (38) (39) (40) . As previously reported (38) , pyroptosis, but not IL-1b maturation and release, was independent from NLRP3 in BMDMs (Fig. 2D, 2F) . Notably, copper chelation did not inhibit the noncanonical activation of NLRP3 ( Fig. 2C-F) , indicating that distinct molecular mechanisms trigger canonical versus noncanonical NLRP3 activation. In accordance with previous reports (37, 41), procaspase-11 expression was induced by LPS priming; however, TTM did not affect the expression of this enzyme (Supplemental Fig. 2D ). These data show that copper chelation blocks the canonical NLPR3 inflammasome specifically without affecting other tested inflammasomes.
Copper chelation inhibits SOD1 activity
TTM is a potent inhibitor of the copper-zinc-dependent SOD1 by removing the copper ion from the active site in cell-free conditions as well as in various nonmyeloid cells in vitro (20, 42, 43) . Accordingly, the copper chelator inhibited the superoxide dismutase activity also in BMDMs in a dose-dependent manner (Fig. 3A) . Aligning SOD1 activity and IL-1b secretion (Fig. 1E) indicates that near-complete inhibition of SOD1 is required for the inhibition of NLRP3 activation. In vivo, a single i.p. dose of 20 mg/kg TTM in wild-type mice reduced SOD1 activity by ∼95% in erythrocytes. The dismutase activity upon treatment with the copper chelator was almost as low as in erythrocyte lysates from SOD1-deficient mice (Fig. 3B ).
We hypothesized that copper chelation abrogates inflammasome activation by inactivating SOD1. If this was true, deletion of SOD1 would inhibit the canonical NLRP3 inflammasome only. To test this, we elicited peritoneal macrophages (PMs) with thioglycolate because SOD1-deficient macrophages cannot be differentiated from BM precursor cells ex vivo. IL-1b release (Fig. 3C ) and pyroptosis (Supplemental Fig. 3A) were strongly reduced in SOD1-deficient PMs compared with wild-type macrophages treated with the canonical NLRP3 stimuli nigericin and ATP, as reported previously (44) . In contrast, NLRP1 and AIM2 inflammasome activation were unaffected in SOD1-deficient cells (Fig. 3C, Supplemental Fig. 3A ). Furthermore, IL-1b secretion and cell death were similar in SOD1-deficient and wild-type PMs upon stimulation with CTxB, a noncanonical caspase-1/-11 activator (Supplemental Fig. 3B) (38) . Also, the activity of the NLRC4 inflammasome postinfection with virulent S. flexneri was comparable between wild-type and SOD1-deficient cells (Supplemental Fig. 3C ). SOD1 deficiency did not affect the expression of pro-IL-1b (Supplemental Fig. 3D ). Importantly, there was a strong reduction in the concentration of the active p20 fragment of caspase-1 in PMs stimulated with ATP and nigericin, but not upon stimulation with poly(dA:dT) or LTx (Supplemental Fig. 3D ). Finally, the secretion of IL-6 and TNF after LPS stimulation was similar in SOD1-deficient and wild-type PMs (Supplemental Fig. 3E ).
To rule out that the inhibitory effect of TTM was independent from superoxide dismutase activity, we treated SOD1-deficient PMs with this chelator. Copper depletion did not affect the residual activation of caspase-1 and IL-1b cleavage in SOD1-deficient cells stimulated with nigericin or ATP (Fig. 3C ), suggesting that TTM specifically attenuates caspase-1 activation by inhibiting SOD1 in macrophages (Fig. 3D ). Our data collectively show that copper depletion specifically blocks canonical NLRP3 activation, phenocopying inflammasome downregulation in SOD1-deficient cells.
Copper depletion alters the intracellular redox state SOD1 deficiency elevates the intracellular level of superoxide anions and alters the intracellular redox milieu (44, 45) . To test whether redox alterations are mechanistically involved in the biological activity of copper chelation, we determined the ratio of GSH to GSSG as a proxy for the redox state in the cytoplasm (46, 47) . Copper chelation shifted the intracellular GSH/GSSG ratio toward oxidation (Fig. 3E ). To confirm this in a complementary approach we used CellROX, a fluorogenic probe that reports alterations of the intracellular redox milieu. Chelation of copper increased the fluorescent signal in BMDMs, and this was reversed by incubating cells with the cell-permeable ROS scavenger N-acetyl-cysteine (NAC) (Fig. 3F) . To link the altered redox state and the inhibition of IL-1b secretion, we treated BMDMs with TTM and NAC before LPS priming and stimulating with nigericin. NAC antagonized the inhibitory effect of TTM on IL-1b secretion and pyroptosis, indicating that copper chelation causes reversible redox alterations (Fig. 3G, 3H) . Notably, in contrast to previously published data (48) (49) (50) , high concentrations of NAC (up to 20 mM at pH-adjusted medium) had no effect on priming or inflammasome activation in our setting (Fig. 3G, 3H) , and the cells were viable with an unaltered cytokine release upon LPS stimulation ( Supplemental Fig. 4A, 4B) .
As previously shown (14) , treatment with diphenyliodonium, a commonly used inhibitor of NOX-dependent ROS production (51), blocked LPS priming efficiently; in contrast, diphenyliodonium treatment after LPS priming had no effect on inflammasome activation and did not affect TTM activity (Supplemental Fig. 4C ). To obtain additional genetic evidence for the role of ROS generating and degrading enzymes in NLRP3 activation, we generated mice deficient for one or two alleles of both NADPH-oxidase 2 (NOX2) and SOD1. We activated BMDMs from these animals and show that the impaired release of mature IL-1b from SOD1deficent cells was not rescued by a deficiency in NOX2. Our genetic data thereby indicate that NOX2-derived ROS is dispensable for the redox-dependent abrogation of NLRP3 activation in our setting (Supplemental Fig. 4D ).
We further investigated whether the SOD1-related phenotype was mechanistically linked to a recently proposed mechanism of NO-mediated suppression of the NLRP3 inflammasome via thiol nitrosylation (52, 53) . Inducible NO synthase (iNOS, alternatively named NOS2) is the major source of NO in BMDMs after LPS and IFN-g activation (Supplemental Fig. 4E ). Copper chelation reduced the secretion of IL-1b in iNOS-deficient BMDMs, pretreated with LPS and IFN-g (Supplemental Fig. 4F ), suggesting that TTM blocks the NLRP3 inflammasome through NOindependent mechanisms.
The cellular redox state regulates NLRP3-dependent ASC speck formation
Upon activation, the adapter protein ASC assembles into a large protein complex, termed speck, a key event in NLRP3 inflammasome activation (54, 55) . We detected fewer cytoplasmic ASCspecks in SOD1-deficient macrophages after LPS priming and stimulation with ATP and nigericin compared with wild-type PMs (Fig. 4A ). However, we did not observe differences in ASC speckling after transfection with poly(dA:dT). Because quantitative analyses were technically difficult in primary macrophages stained with Abs, we used an imaging flow cytometer to quantify ASC specks in immortalized macrophages constitutively expressing ASC fused to the red fluorescent protein mCherry (56) . These cells also express high levels of transgenic NLRP3 and therefore do not require priming. Copper chelation reduced ASC speck formation upon stimulation with nigericin ( Fig. 4B, 4C ). Inflammasome activation in response to transfection with poly(dA:dT) was insensitive to copper depletion. These data locate the requirement of copper for canonical NLRP3 activation upstream of ASC speckling.
Redox sensitivity of NLRP3 activation is cell type dependent
Distinct myeloid cells vary in redox regulation (57, 58) . Hence, we compared the redox sensitivity of the NLRP3 inflammasome in macrophages and monocytes of both mice and humans. Interestingly, PBMCs from wild-type and SOD1-deficient mice, in contrast to caspase-1/-11-deficient mice, released comparable amounts of IL-1b upon LPS priming and stimulation with nigericin ex vivo (Fig. 5A) . In PBMCs the greatest quantity of IL-1b comes from monocytes. As expected, TNF secretion was comparable in SOD1-deficient, wild-type and caspase-1/-11-deficient monocytes (Fig. 5A) . Accordingly, copper chelation did not affect secretion of IL-1b from human blood-derived CD14 high -monocytes stimulated with LPS only (data not shown) or primed with LPS and stimulated with ATP or nigericin (Fig. 5B) . Furthermore, the IL-1b secretion of human monocyte-derived macrophages was not sensitive to copper depletion (Fig. 5C ). In addition, the IL-1b secretion of the myeloid cell lines Mono Mac 6, THP-1, and U937 was also not reduced upon treatment with the copper chelator in vitro (data not shown). To test the effect of TTM in human macrophages, we isolated PMs from patients suffering from a noninfectious accumulation of ascites fluid. The cells were isolated over a density gradient and plated overnight on cell culture dishes. Nonadherent cells were washed off. Cells from seven independent donors were incubated with or without TTM at different concentrations and primed with LPS before stimulation with nigericin. The copper chelation significantly reduced the secretion of IL-1b from human PMs isolated from ascites fluid, whereas TNF secretion was unaffected (Fig. 5D ). These data indicate that intracellular redox regulation shows notable differences between subsets of monocytes and macrophages in human and mouse. In summary, SOD1 regulates NLRP3 activation in macrophages, but not monocytes, and copper is required specifically for canonical NLRP3 activation in macrophages.
Discussion
Copper chelators are anti-inflammatory and have been used for decades to treat patients with rheumatoid arthritis (19, 59, 60) . Unexpectedly, depletion of bioavailable copper did not affect classically secreted proinflammatory cytokine such as TNF, Rantes, and KC, but only reduced unconventionally released caspase-1 dependent cytokines like IL-1. Adding divalent copper abolished the anti-inflammatory properties of TTM completely in vitro, confirming its specificity for complexing copper. Together, we provide several lines of evidence that copper chelation is anti-inflammatory by specifically inhibiting canonical NLRP3 inflammasome activation in mice in vivo as well as in murine and human peritoneal macrophages ex vivo.
In this study, we show that TTM downregulates inflammation by interfering with cellular redox homeostasis. Although ROS are implicated in NLRP3 regulation, the precise mechanism is not understood because the distinct cellular targets of different ROS are not known (61) . In this study we report that depleting bioavailable copper inhibits SOD1, recapitulating the phenotype of SOD1deficient cells (44, 45) . In the absence of SOD1, canonical NLRP3 activators induce the glutathyonylation of caspase-1 (44) . Notably, in this study we show that noncanonical NLRP3-, NLRP1-, NLRC4-, and AIM2-dependent inflammasome activation is not ROS sensitive; therefore we propose that additional posttranslational modifications, such as cysteine oxidations, ubiquitinylation, and phosphorylation (62, 63) , modulate the activation upstream of caspase-1 in macrophages in a redoxsensitive manner. Interestingly, the activation of NLRP3 by imiquimod was also TTM sensitive, a distinct pathway of NLRP3 activation independent from potassium efflux. Accordingly, the association of NLRP3 with NEK7 and ASC speckling was significantly reduced by TTM, clearly locating the proinflammatory role of copper at the level of the interaction of NLRP3 with NEK7 and ASC or other yet to be defined upstream signaling molecules.
A potential source of intracellular ROS upon stimulation is NOX2; however, macrophages from mice deficient in both SOD1 and CYBB, the catalytic subunit of NOX2, show a phenotype comparable to SOD1-deficient cells, suggesting that NOX2-derived ROS play a dispensable role for the redox-dependent NLRP3 inhibition. The inhibition of NLRP3 by copper chelation is reversible, and was abolished in the presence of a high concentration of the cell-permeable ROS scavenger NAC, pointing toward regulatory reversible redox modifications in this immune cell signaling pathway. On the contrary, SOD1-deficient macrophages did not reach a comparable level of NLRP3 activation in the presence of NAC, suggesting a difference in the quality or quantity of the oxidative modifications arising from an enzymatic long-term defect in ROS degradation.
It has been reported that iNOS inhibits the NLRP3 inflammasome by NO-mediated cysteine nitrosylation (52, 53) . In our setting, the redox-sensitive inhibition of NLRP3 was independent of iNOS, suggesting that distinct posttranslational cysteine modifications independently regulate NLRP3. Because reactive nitrogen and oxygen species react with a broad range of molecules, our observations suggest additional redox sensitive cellular targets upstream of NLRP3. Our data therefore indicate that TTM specifically inactivates SOD1, thereby blocking canonical NLRP3 activation by a redox-dependent mechanism.
Interestingly, our data indicate that the requirement for copper is specific to macrophages. Copper chelation did not affect NLRP3 activation in blood-derived monocytes from mice and humans, human blood-derived monocytes, differentiated in vitro into macrophage-like cells as well as the myeloid cell lines Mono Mac 6, THP1, or U937. Although we cannot exclude cell-type specific activation mechanisms, the reported differences in intracellular redox homeostasis of monocytes and macrophages (58) replicates the NLRP3-dependent requirement for copper. In this study we used peritoneal human macrophages from patients with ascites with low cellular counts, and excluded neutrophilic and malignant ascites. As expected, we observed large interindividual differences in macrophage counts and cytokine release; however, these primary human macrophages are available in large numbers without the need of ex vivo differentiation. We do not know the molecular basis of the differences in copper sensitivity among the tested myeloid cells from human and mouse we describe in this study, and further work will be necessary to investigate this more closely.
At high concentrations, TTM was reported to inhibit copperdependent enzymes, such as ceruloplasmin and cytochrome oxidase, or downregulate the transcription factors such as NF-kB and cytokines (20, (64) (65) (66) . Notably, in our setting up to 25 mM TTM did not affect NF-kB-dependent MAPK activation or secretion of classically released cytokines like IL-6 and TNF. At concentrations higher than 50 mM we observed decreased viability of primary macrophages ex vivo, rather than copper-dependent modulation of intracellular signaling or cytokine release. Although, we cannot exclude that NLRP3 inhibition is amplified by additional effects in vivo, our data indicate that the antiinflammatory properties of TTM are mediated by caspase-1dependent mechanisms, whereas NF-kB-dependent mechanisms remained largely unaffected.
TTM is an orally active small molecule that is used in the clinic to treat disorders of copper metabolism. In vivo, depletion of bioavailable copper attenuated caspase-1 activation, reduced serum concentrations of caspase-1 dependent cytokines, decreased lymphocyte cell death, and increased survival in experimental sepsis model. Proteinbased anti-cytokine therapeutics such as anakinra, which blocks the activity of IL-1a and IL-1b, are costly and were unsuccessful for the routine treatment of sepsis in the clinic and of some pathologies in NLRP3-dependent systemic inflammatory syndromes (67, 68) . Pharmacological blockade of the canonical NLRP3 inflammasome might have several advantages over inhibitors of IL-1 (69): IL-18 and pyroptosis play a pivotal role in many pathological inflammatory conditions and remain unaffected by anti-IL-1 therapies (7, 70) .
Because TTM is an approved drug with low toxicity in humans, our data point toward specific therapeutic applications to intervene with NLRP3-dependent pathologies. Besides autoinflammatory and chronic inflammatory conditions, NLRP3 activation is implicated in a growing number of diseases, which were not primarily regarded as inflammatory diseases such as Alzheimer's disease, atherosclerosis, metabolic syndrome, and others (6, 7). Interestingly, TTM has been suggested to have antitumor properties and it
The Journal of Immunology 1615 by guest on March 7, 2020 http://www.jimmunol.org/ will be interesting to investigate the role of blocking NLRP3 to explain antitumor activity. Because TTM did not block the activation of NF-kB and the MAPK pathway or other major antimicrobial inflammasomes such as NLRC4, NLRP1, and AIM2, it may provide a cost-effective, highly specific, and antiinflammatory immune modulator with a good safety profile toward opportunistic infections.
